Factors Predicting Rubella Vaccination among Pregnant Women in Japan: an Interim Report from the Pregnant Women Health Initiative.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
21 Jul 2021
Historique:
pubmed: 5 1 2021
medline: 28 8 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

Following the 2018 rubella outbreak in Japan, this study aimed to assess rubella prevention measures based on the vaccination and immunization status of pregnant women in Japan. Our cohort study involved 3 local core hospitals in Yokohama City, and a total of 666 pregnant women were recruited between June 2018 and September 2019 and answered an online questionnaire. In total, 67.5% of the pregnant women had received rubella vaccination. The rate of rubella vaccination among pregnant women in the present survey was lower than that among age-matched female participants in a nationwide survey conducted in 2018. Overall, the study results showed that pregnant women in their 20s had a higher vaccination rate than those in their 40s, women who were nonsmokers before pregnancy had a higher vaccination rate than those who were smokers, and pregnant women who were aware that rubella may affect their fetuses had a higher vaccination rate than those who were unaware of this. This survey elucidated multiple predictive factors for rubella vaccination among pregnant women in Japan. Our results confirm the recommendation that women considering pregnancy should be vaccinated against rubella.

Identifiants

pubmed: 33390430
doi: 10.7883/yoken.JJID.2020.762
doi:

Substances chimiques

Rubella Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

337-343

Auteurs

Akiko Iwata (A)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Kentaro Kurasawa (K)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Kazumi Kubota (K)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Yoshinobu Sugo (Y)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Mizuha Odagami (M)

Yokohama City University Medical Center, Japan.

Shigeru Aoki (S)

Yokohama City University Medical Center, Japan.

Mika Okuda (M)

National Hospital Organization Yokohama Medical Center, Japan.

Takeharu Yamanaka (T)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Etsuko Miyagi (E)

Yokohama City University School of Medicine Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH